Retatrutide 30mg
$200.00
Retatrutide is a novel triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and glucagon receptors; it represents a groundbreaking advancement in obesity and T2DM pharmacotherapy. Retatrutide is a synthetic peptide which acts as an agonist of GLP-1, GIP, and glucagon receptors. Retatrutide’s engineering allows it to bind uniquely to these receptors.